Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
199.71
+3.13 (1.59%)
At close: Jun 22, 2026, 4:00 PM EDT
199.76
+0.05 (0.02%)
After-hours: Jun 22, 2026, 7:57 PM EDT

Biogen Revenue

Biogen had revenue of $2.48B in the quarter ending March 31, 2026, with 1.93% growth. This brings the company's revenue in the last twelve months to $9.94B, up 1.23% year-over-year. In the year 2025, Biogen had annual revenue of $9.89B with 2.22% growth.

Revenue (ttm)
$9.94B
Revenue Growth
+1.23%
P/S Ratio
2.97
Revenue / Employee
$1,324,987
Employees
7,500
Market Cap
29.48B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.89B214.70M2.22%
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 201914.38B925.00M6.88%
Dec 31, 201813.45B1.18B9.61%
Dec 31, 201712.27B825.10M7.21%
Dec 31, 201611.45B685.00M6.36%
Dec 31, 201510.76B1.06B10.93%
Dec 31, 20149.70B2.77B39.97%
Dec 31, 20136.93B1.42B25.66%
Dec 31, 20125.52B467.83M9.27%
Dec 31, 20115.05B332.21M7.04%
Dec 31, 20104.72B339.07M7.75%
Dec 31, 20094.38B279.84M6.83%
Dec 31, 20084.10B925.89M29.19%
Dec 31, 20073.17B488.57M18.21%
Dec 31, 20062.68B260.55M10.76%
Dec 31, 20052.42B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pfizer63.32B
AstraZeneca60.44B
Novartis AG56.58B
Sanofi54.60B
Novo Nordisk50.57B
Bristol-Myers Squibb Company48.48B
GSK plc43.29B
Amgen37.22B
Revenue Rankings